Sun Pharmaceutical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results for the quarter and year ended 31 March 2026 and recommendation of final dividend for FY 2025-26